Zoya Launches 5-Square-Metre Offline Clinical AI Terminal With 120-Plus Tests

Q: When a doctor and the AI disagree in an emergency, what is the system's protocol for the final clinical decision?

The doctor has the final say. Zoya says ZoyeMed 3.0 is built with a human-in-the-loop design, meaning the AI can support triage, diagnostics and treatment recommendations, but the final clinical decision remains with a licensed clinician. In practice, that means if the AI and the doctor disagree in an emergency, the system is meant to pause at high-risk decision points and require explicit clinician approval before any sensitive action proceeds. The AI can recommend, flag risk, or escalate uncertainty, but it is not supposed to execute or finalize a life-critical decision on its own. That approach is consistent with the broader evidence and regulatory direction cited in the supporting material. High-risk medical AI is expected to include mandatory human oversight, especially in emergencies, to reduce automation bias and preserve professional autonomy. The clinician is also the accountable party for the decision, not the software. Zoya’s immutable, hash-chained audit trail is relevant here because it records each clinical action and approval, creating a traceable record of when the AI advised one course and the clinician chose another. In disconnected or disaster settings, that audit function is especially important for accountability. So the protocol is straightforward: the AI serves as decision support, disagreement triggers clinician review, and the licensed doctor’s judgment overrides the model when a final emergency decision must be made.

1 articles · Updated · Malone Telegram · Jun 17

Zoya Technologies said its new ZoyeMed 3.0 Resilience Edition can deliver a full medical episode in under 30 minutes without any internet connection.
The terminal runs Zoya’s clinical suite and Longitudinal Multimodal Model entirely on-device via its Amygdala edge AI engine, removing the cloud from the care pathway during outages, disasters or remote deployments.
Within a 5-square-metre footprint, the system combines 12-lead ECG, digital stethoscopy, spirometry, fetal Doppler, a 12-camera telepresence array and lab analyzers supporting more than 120 point-of-care tests.
Zoya said the platform can be used in doctor-run, nurse-managed with remote clinician sign-off, or autonomous screening modes, while final clinical decisions remain with a licensed clinician.
The Resilience Edition builds on ZoyeMed deployments already in commercial service since 2025 and adds a hash-chained, append-only audit trail aimed at disconnected operating environments.